Who is sponsoring NCT04630821?

NCT04630821 is sponsored by Northwestern University.

What condition does NCT04630821 study?

NCT04630821 studies Radiation Dermatitis.

What drugs are being tested in NCT04630821?

Interventions: Dilute Sodium Hypochlorite solution.

What is the status of NCT04630821?

NCT04630821 is currently TERMINATED.

Last reviewed 2022-08-17 · How we verify

Utilizing Topical Sodium Hypochlorite to Ameliorate Radiation Dermatitis

NCT04630821 NA TERMINATED

The objective of the pilot study is to determine compliance, acceptability, and feasibility of using topical sodium hypochlorite to ameliorate or reduce radiation dermatitis, and to collect preliminary data and estimates for planning a larger efficacy study. This 3-week single-arm pilot study will collect information on subject treatment compliance and feedback from subjects (and nurses/subject's treating oncologist) on the acceptability of the use of the treatment. We will also collect data on Common Terminology Criteria for Adverse Events and patient reported outcomes measured using the pain and pruritus PROMIS short-form tools and patient reported outcomes, measured using the Dermatology Life Quality Index (DLQI) tool.

Details

Lead sponsor	Northwestern University
Phase	NA
Status	TERMINATED
Enrolment	6
Start date	Mon Feb 08 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Mon Apr 25 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

Radiation Dermatitis

Interventions

Dilute Sodium Hypochlorite solution

Countries

United States